pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Immunology · news · pharmadog
← back to Immunology
News · Immunology
996
stories
Oct 20, 26
Hype vs. reality: What pharma’s hottest R&D bets have actually proved
biopharma dive
Oct 20, 26
Gilead’s ‘highly competitive’ mid-stage ulcerative colitis data ‘validate’ I&I push
biospace
Oct 20, 26
STAT+: The key health care ballot measures we’re watching in the midterms
stat
Oct 20, 26
Lycia aims for $228M IPO to generate data on food allergy rival to Xolair
fiercebiotech
Oct 20, 26
Pfizer makes ‘business decision’ to end phase 2 trial of autoimmune drug as program’s future uncertain
fiercebiotech
Oct 20, 26
AstraZeneca taps Oracle to help improve recruitment for clinical trials
fiercebiotech
Oct 19, 26
Trump orders creation of NIH division, task force on women’s health
stat
Oct 19, 26
FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery
fda press
Oct 19, 26
As AbbVie’s Crohn’s combo beats Skyrizi in mid-stage test, analysts laud autoimmune vision
biospace
Oct 19, 26
Two former Republican lawmakers say the GOP’s vaccine position is a liability
stat
Oct 19, 26
Novartis ends mid-stage Fabhalta study in lupus, insists no efficacy or safety issues
biospace
Oct 19, 26
Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness study
biopharma dive
Oct 19, 26
STAT+: Gilead’s IBD drug eliminated symptoms for patients, mid-stage study finds
stat
Oct 19, 26
STAT+: Top immunology association divided over $8.4-billion California ballot measure to fund the field, emails show
stat
Oct 19, 26
Israeli biotech’s inhaled exosome therapy reduces respiratory failure in phase 2 study
fiercebiotech
Oct 19, 26
Merck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026
biospace
Oct 19, 26
More arms, more questions: The new challenge in multispecific drug design
biospace
Oct 16, 26
Iambic CEO on taking an AI drug company public
biopharma dive
Oct 16, 26
What to read before you go see that new documentary on Elizabeth Holmes
stat
Oct 16, 26
iPSCs come of age, powering breakthroughs in the lab and clinic
biospace
Oct 16, 26
Nouscom raises $135M for pivotal trial of cancer-preventing vaccine candidate
fiercebiotech
Oct 16, 26
Lidl US Recalls Gelatelli Coffee & Vanilla Gelato Due to Possible Health Risk
fda recalls
Oct 15, 26
Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success
stat
Oct 15, 26
Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions
fiercebiotech
Oct 15, 26
Belgian startup revives Galapagos CAR-T research
biopharma dive
Oct 15, 26
Osivax pivots to combo approach after flu jab fails in Phase 2b
endpoints
Oct 15, 26
Stoffels strikes up new biotech in return to Galapagos cell therapy mission
biospace
Oct 15, 26
STAT+: On Wall Street, there’s trouble stirring for biotech
stat
Oct 15, 26
Osivax focuses on combo strategy for flu vaccine after phase 2 fail
fiercebiotech
Oct 15, 26
Rebranded Galapagos finally finds buyer for unwanted cell therapy pipeline
fiercebiotech
← prev
page 8 of 34
next →